From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Steve O'Hara of Optibiotix blames interviews with me for share price weakness

By Tom Winnifrith | Thursday 7 January 2021


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Yup, if he does an interview with me and my tough questions, shares in Optibiotix (OPTI) go down.  So, going forward, it is only those paid-for interviews with folks like Proactive. “Steve, is your schlonger enormous or gigantic? Why are your shares so cheap? etc etc.” Whatever, I apologise to you all for asking the odd question. Without my malign influence, Optibiotix would clearly be in the FTSE 100. I discuss this company’s prospects and also those of Skinbiotherapeutics (SBTX) where I am also a loyal shareholder. I look at Trainline (TRN), Online Blockchain (OBC) and Vast Resources (VAST).

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 23:41:25